(Q39354500)

11 September 2017

title

Clinical and serological analysis of transfusion-associated hepatitis (English)

1 reference

11 September 2017

1

H J Alter

1 reference

11 September 2017

4

R H Purcell

1 reference

11 September 2017

P. V. Holland

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A53329

8 April 2022

A. G. Morrow

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A53329

8 April 2022

S. M. Feinstone

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A53329

8 April 2022

Y. Moritsugu

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A53329

8 April 2022

language of work or name

English

0 references

publication date

1 November 1975

1 reference

full work available at URL

11 September 2017

https://api.elsevier.com/content/article/PII:S0140673675902342?httpAccept=text/xml

1 reference

10.1016/S0140-6736(75)90234-2

DOI

https://api.crossref.org/works/10.1016/S0140-6736(75)90234-2

https://api.elsevier.com/content/article/PII:S0140673675902342?httpAccept=text/plain

8 April 2022

1 reference

10.1016/S0140-6736(75)90234-2

DOI

https://api.crossref.org/works/10.1016/S0140-6736(75)90234-2

8 April 2022

1 reference

11 September 2017

volume

2

1 reference

11 September 2017

issue

7940

1 reference

11 September 2017

page(s)

838-841

1 reference

Posttransfusion hepatitis after open-heart operations. Incidence after the administration of blood from commercial and volunteer donor populations

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

Reduction of post-transfusion hepatitis by exclusion of Australia antigen from donor blood in an urban public hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

Serum glutamic pyruvic transaminase in cardiac with hepatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

Hemagglutination Assay for Antigen and Antibody Associated with Viral Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

Specific Immune Adherence Assay for Human Hepatitis A Antibody. Application to Diagnostic and Epidemiologic Investigations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

Seroepidemiological studies of transfusion-associated hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

Protective effect of pre-irradiation on lymphocytic choriomeningitis infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

Hepatitis B antigen and prevention of post-transfusion hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

Post-transfusion hepatitis in recipients of blood screened by newer assays

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

Limitations of Solid-Phase Radioimmunoassay for HB Ag in Reducing Frequency of Post-Transfusion Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

Specificity of the direct solid-phase radioimmunoassay for detection of hepatitis-B antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

A prospective study indicating that double-antibody radioimmunoassay reduces the incidence of post-transfusion hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

Comparison of the Sensitivities of the Newer Detection Systems for Hepatitis B Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

A prospective study of posttransfusion hepatitis. The role of Australia Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

Transfusion-Associated Hepatitis Not Due to Viral Hepatitis Type A or B

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2875%2990234-2

7 January 2021

10.1016/S0140-6736(75)90234-2

Identifiers

DOI

1 reference

11 September 2017

1 reference